Artificial intelligence in intensive care units: German Heart Center Berlin becomes x-cardiac pilot customer
22.09.2022 11:56
Software developed by Berlin-based x-cardiac GmbH for the AI-based prediction of complications after heart surgery is being used in everyday clinical practice for the first time at the German Heart Center Berlin. Bleeding and acute kidney failure are among the most dangerous complications after operations on the heart or vessels close to the heart. The earlier they are detected, the greater the chance of successful treatment measures.
x-cardiac develops artificial intelligence-based software that has been trained to detect these complications early using stored and anonymized data from tens of thousands of patients. The certified medical product “xc-bleeding” that emerged from this development for the prediction of postoperative bleeding is now being installed in everyday clinical practice for the first time in the intensive care unit of the German Heart Center Berlin (DHZB).
According to the developers, “xc-bleeding” detects an increased probability of secondary bleeding based on even the slightest changes in the standard measurements taken in an intensive care unit. The medical staff can quickly initiate the necessary measures to confirm the prognosis and treatment.
The everyday work of doctors and intensive care nurses should be made easier with the software and at the same time it should ensure a high level of safety and treatment quality for patients, says Prof. Dr. med. Alexander Meyer, doctor at the DHZB and managing director of x-cardiac, “a real win-win situation!”
Managing director Oliver Höppner adds: “With this important step, our first medical product has arrived in everyday clinical practice, and further pilot customers are already in the pipeline. At the same time, our team is working highly motivated on the development and certification of a next generation of products, which will not only predict postoperative bleeding but also acute kidney failure after heart surgery.”
x-cardiac was founded at the end of 2020 with the support of the DHZB as well as the Berlin Institute of Health (BIH) and the Charité-Universitätsmedizin Berlin. The medical device “xc-bleeding” meets all requirements for eligibility as a clinical decision support system within the framework of the Hospital Future Act (KHZG), with which the Federal Ministry of Health is funding digitalization in German hospitals with a total of up to 4.3 billion euros.